Introduction Aplastic Anemia (AA) is a rare and life-threatening bone marrow failure disorder characterised by the lymphocyte-mediated destruction of early hematopoietic cells (1). Because of its high potential for morbidity and mortality, a systematic and rapid approach to its management is essential (1). A rapid and accurate diagnosis is critical